Free Trial

InspireMD (NSPR) Competitors

InspireMD logo
$2.43 -0.01 (-0.41%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$2.50 +0.07 (+3.09%)
As of 07/25/2025 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NSPR vs. CLPT, OM, RXST, NPCE, NNOX, NYXH, DRTS, STIM, ZIMV, and SMTI

Should you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include ClearPoint Neuro (CLPT), Outset Medical (OM), RxSight (RXST), NeuroPace (NPCE), Nano-X Imaging (NNOX), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Neuronetics (STIM), ZimVie (ZIMV), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry.

InspireMD vs. Its Competitors

ClearPoint Neuro (NASDAQ:CLPT) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

ClearPoint Neuro presently has a consensus target price of $25.00, indicating a potential upside of 122.62%. InspireMD has a consensus target price of $4.50, indicating a potential upside of 85.19%. Given ClearPoint Neuro's higher probable upside, analysts clearly believe ClearPoint Neuro is more favorable than InspireMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ClearPoint Neuro
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
InspireMD
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, ClearPoint Neuro had 2 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for ClearPoint Neuro and 1 mentions for InspireMD. ClearPoint Neuro's average media sentiment score of 1.27 beat InspireMD's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ClearPoint Neuro
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InspireMD
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

ClearPoint Neuro has a net margin of -64.51% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
ClearPoint Neuro-64.51% -78.09% -51.33%
InspireMD -413.96%-69.42%-57.68%

ClearPoint Neuro has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

ClearPoint Neuro has higher revenue and earnings than InspireMD. ClearPoint Neuro is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ClearPoint Neuro$32.24M9.75-$18.91M-$0.76-14.78
InspireMD$7.03M10.59-$19.92M-$0.79-3.08

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 7.0% of ClearPoint Neuro shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

ClearPoint Neuro beats InspireMD on 10 of the 15 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NSPR vs. The Competition

MetricInspireMDSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$74.44M$65.61M$5.70B$21.11B
Dividend YieldN/AN/A4.60%3.60%
P/E Ratio-3.246.1628.1028.44
Price / Sales10.59139.16429.3758.65
Price / CashN/A18.4136.2222.92
Price / Book1.337.298.664.69
Net Income-$19.92M-$25.32M$3.25B$995.51M
7 Day Performance1.67%0.81%4.22%1.65%
1 Month Performance7.52%8.52%10.51%4.54%
1 Year Performance-28.32%54.51%34.40%9.99%

InspireMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NSPR
InspireMD
2.5429 of 5 stars
$2.43
-0.4%
$4.50
+85.2%
-18.5%$74.44M$7.03M-3.2450
CLPT
ClearPoint Neuro
2.1262 of 5 stars
$10.98
-0.5%
$25.00
+127.7%
+48.5%$308.72M$31.39M-14.45110News Coverage
Positive News
OM
Outset Medical
1.5534 of 5 stars
$17.51
+0.5%
$29.50
+68.5%
-66.7%$308.72M$113.69M-0.60520Positive News
RXST
RxSight
2.4605 of 5 stars
$7.35
flat
$17.50
+138.1%
-82.4%$298.68M$139.93M-10.97220Trending News
NPCE
NeuroPace
3.4522 of 5 stars
$9.36
+3.3%
$17.00
+81.6%
+10.6%$297.15M$79.91M-11.14170News Coverage
Positive News
NNOX
Nano-X Imaging
1.9303 of 5 stars
$5.17
+0.6%
$9.50
+83.8%
-33.8%$296.98M$11.28M-5.74190News Coverage
Positive News
NYXH
Nyxoah
2.523 of 5 stars
$7.94
-3.4%
$14.50
+82.6%
-10.6%$279.98M$4.89M-3.73110Positive News
DRTS
Alpha Tau Medical
2.8448 of 5 stars
$2.98
-2.0%
$8.00
+168.5%
+44.0%$257.85MN/A-6.4880
STIM
Neuronetics
1.4932 of 5 stars
$3.88
+6.0%
$5.50
+41.8%
+137.6%$241.98M$74.89M-2.96180Positive News
ZIMV
ZimVie
0.5308 of 5 stars
$18.76
+122.3%
$16.33
-12.9%
-13.8%$235.03M$449.75M-26.421,770News Coverage
Analyst Upgrade
High Trading Volume
SMTI
Sanara MedTech
2.0107 of 5 stars
$26.28
-0.1%
$49.50
+88.4%
-20.7%$233.84M$86.67M-19.6160Positive News

Related Companies and Tools


This page (NYSE:NSPR) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners